James H. Schluger

1.8k total citations · 1 hit paper
13 papers, 1.4k citations indexed

About

James H. Schluger is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, James H. Schluger has authored 13 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 6 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in James H. Schluger's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Neuropeptides and Animal Physiology (6 papers) and Stress Responses and Cortisol (4 papers). James H. Schluger is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Neuropeptides and Animal Physiology (6 papers) and Stress Responses and Cortisol (4 papers). James H. Schluger collaborates with scholars based in United States and France. James H. Schluger's co-authors include Mary Jeanne Kreek, Lisa Borg, Mingting Tian, J.A. Strong, Lei Yu, Cherie E. Bond, K. Steven LaForge, Shengwen Zhang, Jay A. Tischfield and Dorothy Melia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

James H. Schluger

13 papers receiving 1.4k citations

Hit Papers

Single-nucleotide polymorphism in the human mu opioid rec... 1998 2026 2007 2016 1998 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James H. Schluger United States 12 741 374 367 352 199 13 1.4k
Matthew Randesi United States 20 570 0.8× 391 1.0× 225 0.6× 177 0.5× 204 1.0× 48 1.2k
Mingting Tian United States 7 1.0k 1.4× 756 2.0× 504 1.4× 344 1.0× 156 0.8× 9 1.6k
Cherie E. Bond United States 12 493 0.7× 363 1.0× 349 1.0× 313 0.9× 216 1.1× 15 1.2k
Dorothy Melia United States 6 401 0.5× 203 0.5× 273 0.7× 319 0.9× 162 0.8× 7 1.0k
Evelyne Célèrier France 16 906 1.2× 342 0.9× 1.3k 3.4× 575 1.6× 285 1.4× 17 1.9k
J H Mendelson United States 24 808 1.1× 435 1.2× 176 0.5× 47 0.1× 360 1.8× 36 1.7k
Joseph R. Holtman United States 19 284 0.4× 196 0.5× 339 0.9× 158 0.4× 93 0.5× 38 1.0k
Jean‐Paul Laulin France 19 1.0k 1.4× 441 1.2× 1.5k 4.1× 762 2.2× 344 1.7× 31 2.4k
Megan J. Shram Canada 16 539 0.7× 458 1.2× 214 0.6× 102 0.3× 95 0.5× 32 949
M J Kreek United States 14 499 0.7× 276 0.7× 148 0.4× 48 0.1× 75 0.4× 26 943

Countries citing papers authored by James H. Schluger

Since Specialization
Citations

This map shows the geographic impact of James H. Schluger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James H. Schluger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James H. Schluger more than expected).

Fields of papers citing papers by James H. Schluger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James H. Schluger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James H. Schluger. The network helps show where James H. Schluger may publish in the future.

Co-authorship network of co-authors of James H. Schluger

This figure shows the co-authorship network connecting the top 25 collaborators of James H. Schluger. A scholar is included among the top collaborators of James H. Schluger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James H. Schluger. James H. Schluger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Bart, Gavin, James H. Schluger, Lisa Borg, et al.. (2005). Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity?. Neuropsychopharmacology. 30(12). 2254–2262. 109 indexed citations
3.
Bart, Gavin, Lisa Borg, James H. Schluger, et al.. (2003). Suppressed Prolactin Response to Dynorphin A1–13 in Methadone-Maintained Versus Control Subjects. Journal of Pharmacology and Experimental Therapeutics. 306(2). 581–587. 33 indexed citations
4.
Schluger, James H., Gavin Bart, Mark A. Green, Ann Ho, & Mary Jeanne Kreek. (2003). Corticotropin-Releasing Factor Testing Reveals a Dose-Dependent Difference in Methadone Maintained Vs Control Subjects. Neuropsychopharmacology. 28(5). 985–994. 49 indexed citations
5.
Stokes, Peter E., et al.. (2002). Hypercortisolemia decreases dexamethasone half-life in rabbit. Journal of Psychiatric Research. 36(6). 423–428. 11 indexed citations
6.
Schluger, James H.. (2001). Altered HPA Axis Responsivity to Metyrapone Testing in Methadone Maintained Former Heroin Addicts with Ongoing Cocaine Addiction. Neuropsychopharmacology. 24(5). 568–575. 67 indexed citations
7.
Kling, Mitchel A., Richard E. Carson, Lisa Borg, et al.. (2000). Opioid Receptor Imaging with Positron Emission Tomography and [18F]Cyclofoxy in Long-Term, Methadone-Treated Former Heroin Addicts. Journal of Pharmacology and Experimental Therapeutics. 295(3). 1070–1076. 86 indexed citations
8.
Kreek, Mary Jeanne, James H. Schluger, L.A.H. Borg, Mithat Gunduz, & A. Ho. (1999). Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions. Journal of Pharmacology and Experimental Therapeutics. 288(1). 260–269. 75 indexed citations
9.
King, Andrea C., Ann Ho, James H. Schluger, Lisa Borg, & Mary Jeanne Kreek. (1999). Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects. Drug and Alcohol Dependence. 54(1). 87–90. 13 indexed citations
10.
Perret, Guillaume, et al.. (1998). Downregulation of 5-HT1A receptors in rat hypothalamus and dentate gyrus after ?binge? pattern cocaine administration. Synapse. 30(2). 166–171. 27 indexed citations
11.
Bond, Cherie E., K. Steven LaForge, Mingting Tian, et al.. (1998). Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction. Proceedings of the National Academy of Sciences. 95(16). 9608–9613. 855 indexed citations breakdown →
12.
Schluger, James H., Ann Ho, Lisa Borg, et al.. (1998). Nalmefene Causes Greater Hypothalamic‐Pituitary‐Adrenal Axis Activation than Naloxone in Normal Volunteers: Implications for the Treatment of Alcoholism. Alcoholism Clinical and Experimental Research. 22(7). 1430–1436. 78 indexed citations
13.
Perret, Guillaume, et al.. (1998). Downregulation of 5‐HT1A receptors in rat hypothalamus and dentate gyrus after “binge” pattern cocaine administration. Synapse. 30(2). 166–171. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026